DHR Danaher Corporation
$220.36 -3.16%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-3.16%
YTD
-3.70%
P/E
36.09
P/B
3.08
ROE
8.2%
Div yield
0.5%
Beta
0.58
Market cap
$156.3B
RSI (14)
41
Next earnings
Jan 26, 2027
Same sector · Health Care
Compare DHR with NVO and JNJ →Follow DHR in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$228.10
Close
$220.36
Day high
$228.17
Day low
$219.92
Volume
4.0M
Latest headlines
Lendmark Financial Services Earns National Recognition for Turning Talent Into Long-Term Careers
Yahoo Finance · Nov 20
Danaher (DHR) Down 1% Since Last Earnings Report: Can It Rebound?
Yahoo Finance · Nov 20
Stanley Druckenmiller, Dan Loeb and 12 Other Big Funds Sold Danaher Last Quarter, While 26 Bought. Who’s Right?
Yahoo Finance · Nov 20
Danaher Teams Up With Microsoft To Develop AI-Powered Scientific Instruments, First Applications Expected This Year
Yahoo Finance · Nov 20
Danaher Collaborates with Microsoft to Make Scientific Instruments Agentically Connected and Laboratories More Intelligent
Yahoo Finance · Nov 20
Point-of-Care/Rapid Diagnostics - Global Strategic Business Report 2026: Capture a $40.7 Billion Market by 2032 with Abbott, Roche, Danaher and Siemens
Yahoo Finance · Nov 19
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 21, 2026 View → 10-Q Oct 21, 2026 View → 8-K Oct 13, 2026 View → 8-K Aug 3, 2026 View → 8-K Jul 21, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell DHR. Try it in the Lab to size a position and see the risk.